下载掌阅APP，畅读海量书库
立即打开
［1］CHAN L Y, LEUNG J C, TANG S C, et al. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy [J]. J Am Soc Nephrol, 2005, 16 (8): 2306-2317.
［2］LAM S, VERHAGEN N A, STRUTZ F, et al. Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-beta1 [J]. Kidney Int, 2003, 63 (3): 878-888.
［3］CHAN L Y, LEUNG J C, TSANG A W, et al. Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy [J]. Kidney Int, 2005, 67 (2): 602-612.
［4］LAI K N, CHAN L Y, LEUNG J C. Mechanisms of tubulointerstitial injury in IgA nephropathy [J]. Kidney Int Suppl, 2005,(94): S110-S115.
［5］KANG D H, KANELLIS J, HUGO C, et al. Role of the microvascular endothelium in progressive renal disease [J]. J Am Soc Nephrol, 2002, 13 (3): 806-816.
［6］CHOW K M, SZETO C C, LAI F M, et al. Genetic polymorphism of vascular endothelial growth factor: impact on progression of IgA nephropathy [J]. Ren Fail, 2006, 28 (1): 15-20.
［7］BARRATT J, SMITH A C, MOLYNEUX K, et al. Immunopathogenesis of IgAN [J]. Semin Immunopathol, 2007, 29 (4): 427-443.
［8］INOUE T, SUGIYAMA H, KIKUMOTO Y, et al. Downregulation of the beta1, 3-galactosyltransferase gene in tonsillar B lymphocytes and aberrant lectin bindings to tonsillar IgA as a pathogenesis of IgA nephropathy [J]. Contrib Nephrol, 2007, 157: 120-124.
［9］HUANG H, PENG Y, LIU F, et al. Is IgA nephropathy induced by abnormalities of CD4 + CD25 + Treg cells in the tonsils [J]. Med Hypotheses, 2007, 69 (2): 410-413.
［10］BUREN M, YAMASHITA M, SUZUKI Y, et al. Altered expression of lymphocyte homing chemokines in the pathogenesis of IgA nephropathy [J]. Contrib Nephrol, 2007, 157: 50-55.
［11］HELLER F, LINDENMEYER M T, COHEN C D, et al. The contribution of B cells to renal interstitial inflammation [J]. Am J Pathol, 2007, 170 (2): 457-468.
［12］MYLLYMAKI J M, HONKANEN T T, SYRJANEN J T, et al. Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy [J]. Kidney Int, 2007, 71 (4): 343-348.
［13］MOLDOVEANU Z, WYATT R J, LEE J Y, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels [J]. Kidney Int, 2007, 71 (11): 1148-1154.
［14］WYATT RJ, JJLIAN BA. IgA nephropathy [J]. N Engl J Med, 2013, 368 (25): 2402-2414.
［15］MESTECKY J, RASKA M, JULIAN BA, et al. IgA nephropathy: molecular mechanisms of the disease [J]. Annu Rev Pathol, 2013, 8: 217-240.
［16］NOVAK J, JJLIAN B A, TOMANA M, et al. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy [J]. Semin Nephrol, 2008, 28 (1): 78-87.
［17］BUCK K S, SMITH A C, MOLYNEUX K, et al. B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy [J]. Kidney Int, 2008, 73 (10): 1128-1136.
［18］SUZUKI H, MOLDOVEANU Z, HALL S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1 [J]. J Clin Invest, 2008, 118 (2): 629-639.
［19］IWANAMI N, IWASE H, TAKAHASHI N, et al. Similarities between N-glycan glycoform of tonsillar IgA1 and that of aberrant IgA1 abundant in IgA nephropathy patient serum [J]. J Nephrol, 2008, 21 (1):118-126.
［20］MACAULEY M S, CROCKER P R, PAULSON J C. Siglec-mediated regulation of immune cell function in disease [J]. Nat Rev Immunol, 2014, 14 (10): 653-666.
［21］DING H, HE Y, LI K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy [J]. Clin Immunol, 2007, 123 (2): 227-234.
［22］IMAKIIRE T, KIKUCHI Y, YAMADA M, et al. Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis [J]. Hypertens Res, 2007, 30 (7): 635-642.
［23］BICANSKI B, WENDERDEL M, MERTENS PR, et al. PDGF-B gene single-nucleotide polymorphisms are not predictive for disease onset or progression of IgA nephropathy [J]. Clin Nephrol, 2007, 67 (2): 65-72.
［24］PARLONGO G, TRIPEPI G, ZOCCALI C. About the manuscript of Nishitani Y et al.(Kidney Int 2005; 68: 1078-1085)[J]. Kidney Int, 2006, 69 (6): 1092.
［25］EIJGENRAAM J W, WOLTMAN A M, KAMERLING S W, et al. Dendritic cells of IgA nephropathy patients have an impaired capacity to induce IgA production in naive B cells [J]. Kidney Int, 2005, 68 (4): 1604-1612.